[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation

American Journal of Respiratory and Critical Care Medicine

Volumn 180, Issue 6, 2009, Pages 533-539

  Chen, Delphine L ^a   Bedient, Timothy J ^b   Kozlowski, James ^a   Rosenbluth, Daniel B ^b   Isakow, Warren ^b   Ferkol, Thomas W ^b   Thomas, Betsy ^a   Mintun, Mark A ^a   Schuster, Daniel P ^a,b   Walter, Michael J ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Drug development; Lovastatin; Neutrophils

Indexed keywords

DROTRECOGIN; ENDOTOXIN; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PLACEBO; DIAGNOSTIC AGENT; HYPOCHOLESTEROLEMIC AGENT; PROTEIN C; RADIOPHARMACEUTICAL AGENT; RECOMBINANT PROTEIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; NEUTROPHIL COUNT; NORMAL HUMAN; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METHODOLOGY; SCINTISCANNING;

ADULT; ANTICHOLESTEREMIC AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; DOUBLE-BLIND METHOD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MALE; NEUTROPHIL ACTIVATION; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; PROTEIN C; RADIOPHARMACEUTICALS; RECOMBINANT PROTEINS; YOUNG ADULT;

EID: 69949097546     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200904-0501OC     Document Type: Article

References (29)

1. Lee WL, Downey GP. Neutrophil activation and acute lung injury. Curr Opin Crit Care 2001;7:1-7. (Pubitemid 32163422)
2. Perl M, Lomas-Neira J, Chung CS, Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury - a unifying hypothesis? What we have learned from small interfering RNAs. Mol Med 2008;14:465-475.
3. Martin TR. Neutrophils and lung injury: getting it right. J Clin Invest 2002;110:1603-1605.
4. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest 2008;133:489-495.
5. Pettersen CA, Adler KB. Airways inflammation and COPD: epithelial-neutrophil interactions. Chest 2002;121(5 Suppl):142S-150S.
6. Selby C, Drost E, Lannan S, Wraith PK, MacNee W. Neutrophil retention in the lungs of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991;143:1359-1364.
7. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-1539.
8. Zhang JY, Wenzel SE. Tissue and BAL based biomarkers in asthma. Immunol Allergy Clin North Am 2007;27:623-632; vi.
9. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997;156:737-743.
10. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995;95:843-852.
11. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005;25:640-646. (Pubitemid 40528756)
12. Ilumets H, Rytila PH, Sovijarvi AR, Tervahartiala T, Myllarniemi M, Sorsa TA, Kinnula VL. Transient elevation of neutrophil proteinases in induced sputum during COPD exacerbation. Scand J Clin Lab Invest 2008;9:1-6.
13. Reid DW, Misso N, Aggarwal S, Thompson PJ, Walters EH. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis. Respirology 2007;12:63-69. (Pubitemid 44968201)
14. 18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004;286:L834-L840.
15. Jones H, Clark R, Rhodes C, Schofield J, Krausz T, Haslett C. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994;149:1635-1639.
16. Jones H, Sriskandan S, Peters A, Pride N, Krausz T, Boobis A, Haslett C. Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J 1997;10:795-803. (Pubitemid 27180189)
17. 18F]fluoro-D-glucose during acute lung injury. Acad Radiol 2008;15:763-775.
18. Chen DL, Ferkol TW, Mintun MA, Pittman JE, Rosenbluth DB, Schuster DP. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 2006;173:1363-1369. (Pubitemid 43900711)
19. Chen DL, Rosenbluth DB, Mintun MA, Schuster DP. FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin. J Appl Physiol 2006;100:1602-1609.
20. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF. Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med 2001;163:1591-1598. (Pubitemid 32578761)
21. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, et al. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004;104:3878-3885. (Pubitemid 39620133)
22. Hothersall E, McSharry C, Thomson NC. Potential therapeutic role for statins in respiratory disease. Thorax 2006;61:729-734. (Pubitemid 44211783)
23. Meinert CL, Tonascia S. Clinical trials: design, conduct, and analysis. New York: Oxford University Press; 1986.
24. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985;5:584-590.
25. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983;3:1-7.
26. Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, et al. IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 2006;174:461-470. (Pubitemid 44223128)
27. Jones HA, Marino PS, Shakur BH, Morrell NW. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 2003;21:567-573.
28. Zhou Z, Kozlowski J, Goodrich AL, Markman N, Chen DL, Schuster DP. Molecular imaging of lung glucose uptake after endotoxin in mice. Am J Physiol Lung Cell Mol Physiol 2005;289:L760-L768. (Pubitemid 41504407)
29. Kuipers HF, van den Elsen PJ. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis. Biomed Pharmacother 2007;61:400-407.